Intentional and inadvertent intraocular administration of aminoglycosides is associated with cases of retinal toxicity. Clinical manifestations resemble a vaso-occlusive event and include edema, intraretinal hemorrhage, and nonperfusion detected by fluorescein angiogram. This study was conducted to measure the retinal function in avascular and isolated perfused retinas to separate vascular and neurologic effects of gentamicin. Enhanced understanding of the mechanism of gentamicin toxicity may lead to development of aminoglycosides that can be used to treat ophthalmic infections without retinal damage. METHODS. Whole animals and isolated rabbit and rat retina preparations were used to study the dose dependence and reversibility of toxicity on the ERG, with a 1-and a 10-mg/mL solution of gentamicin. The amplitude and implicit times of the a-, b-, and c-waves were measured before, during, and after exposure to the drug. RESULTS. In whole-animal ERG studies, intraocular administration of gentamicin eliminated the b-wave but left the a-wave intact. The c-wave was reduced in amplitude. Histopathologic evaluation demonstrated diffuse disruption of the nerve fiber layer and the inner plexiform layers. Isolated retinal studies showed that the b-wave was reduced in amplitude in the presence of low-dose gentamicin (1 mg/mL) and completely eliminated by high-dose gentamicin (10 mg/mL). This effect was reversible for short-term exposure to gentamicin. CONCLUSIONS. The results indicate that the initial loss of function due to exposure to aminoglycoside antibiotics is independent of the vascular supply. Elimination of the b-wave was dose dependent and reversible, indicating that a component of gentamicin toxicity is mediated through pathways other than vascular supply. Short-term effects are reversible, suggesting a receptor-mediated process. (Invest Ophthalmol Vis Sci. 2005; 46:4804 -4808)
T he aminoglycosides are a class of drugs with antibiotic action secondary to their ability to inhibit bacterial protein synthesis at the ribosome. 1 Commonly used aminoglycosides include tobramycin, amikacin, and gentamicin. Gentamicin has been used in the treatment of endophthalmitis and anterior segment infection and for postoperative prophylaxis because of its activity against Gram-negative organisms. 2 It is cleared from the eye by the anterior chamber and has a half-life of 33 hours. 3 Although aminoglycosides are well known to be associated with oto- 4 and nephrotoxicity 5 with systemic use, it has recently been recognized that there is ocular toxicity with local administration as well.
Several cases of retinal toxicity have been reported after aminoglycoside use for the treatment or prophylaxis of endophthalmitis. Loss of visual function has been reported after administration of gentamicin, amikacin, and tobramycin. 6 Acutely, the retina becomes opaque and edematous with superficial and intraretinal hemorrhages, cotton wool spots, arteriolar narrowing, and venous beading. Fluorescein angiography reveals severe vascular nonperfusion, 7 and ERG responses are extinguished. Chronic findings include neovascular glaucoma, pigmentary degeneration, optic atrophy, and severe visual loss. 8 After inadvertent intraocular injection of aminoglycoside, vision loss can, in some cases, be prevented with lavage of the anterior chamber and early vitrectomy. 9 Several studies of aminoglycoside toxicity in animal models have shown vascular changes similar to those in clinical cases. A 10-mg injection of gentamicin in primate vitreous caused whitening of the retina, retinal hemorrhages, multiple areas of vascular leakage, and loss of the a-and b-wave from the ERG. These changes mimic acute central retinal artery obstruction. 10 Conway et al. 11 demonstrated marked swelling of the nerve fiber layer and ganglion cell necrosis with preservation of normal vasculature after intravitreal injection of 1 mg gentamicin. Hines et al. 12 showed that vacuolization of the nerve fiber layer and disruption of the inner nuclear layer occur within 12 hours of gentamicin administration, followed later by vascular congestion and leukocyte margination. Mochizuki et al. 13 described loss of the a-and b-waves and the oscillatory potentials 7 to 14 days after a 0.24-mg intravitreal injection of gentamicin in rabbits.
The mechanism of retinal toxicity of aminoglycosides remains unclear. The striking clinical presentation of capillary nonperfusion after aminoglycoside administration has suggested a primarily vascular mechanism. Because gentamicin is a strong acid, it has been suggested that toxicity may be a direct pH effect 14 or that it may accumulate in the acidic environment of the lysosome and cause disruption of RPE metabolism. 15 To elucidate further the mechanism of the retinal toxicity of aminoglycosides, we examined both wholeanimal ERGs in rabbits and the in vitro ERG responses of rabbit and rat retinas, both of which represent retinal preparations removed from their normal blood supply. The isolated retinal preparations also facilitated rapid and reversible exposure of the retina to gentamicin. Elucidation of the mechanism of gentamicin toxicity may lead to development of aminoglycosides that can be used to treat ophthalmic infections without retinal damage. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.isolated retinal preparations (n ϭ 5), animals were dark adapted for at least 12 hours before death, rats were killed by carbon dioxide asphyxiation and rabbits by pentobarbital sodium overdose. Eyes were enucleated with IR-sensitive goggles (AN/PVS-5 Nightvision Goggles; ITT, Roanoke, VA [among others]), eyecups were prepared (Leibovitz L-15 medium; Invitrogen-Gibco Corp., Carlsbad, CA), and neural retinas were teased away from the RPE. All subsequent preparation was performed in the dark with the aid of infrared image converters (Dark Invader; BE Meyers Inc., Redmond, WA) attached to the dissecting microscope eyepieces.
METHODS

Isolated Retinal Preparation
A disc of retina with approximately 6-mm diameter was mounted in a Ussing chamber (World Precision Instruments, Sarasota, FL) modified to receive a fiber optic. The photoreceptor side of the retina faced the fiber optic, whereas the ganglion cell layer (GCL) side was supported by a filter paper. Electrodes connected to the Ussing chamber consisted of Ag/AgCl pellets. The Ussing chamber was attached to a system that perfused warm, bubbled (95% O 2 -5% CO 2 ) Ames' medium at a rate of approximately 1 mL/min. Flow was calibrated at the beginning and end of each experiment. Two perfusion lines delivered Ames medium from the heated beakers to the Ussing chamber. One line delivered control medium to the photoreceptor side, and a second line fed the ganglion cell side. This line was configured to deliver either control medium or medium containing gentamicin. The Ussing chamber was perfused with warm solutions heated in water-jacketed beakers (Radnoti, Monrovia, CA) and oxygenated through plastic tubing. The water bath was heated and circulated with a temperature-controlled water pump (Polyscience, Niles, IL). Perfusion lines were heated with a DC power supply (Topward; SpenceTek Inc., Milpitas, CA). The temperature was calibrated at the location of the retina to 37°C. After baseline isolated-tissue ERG responses were recorded (DC to 300 Hz), test medium containing 1 or 10 mg/mL gentamicin was perfused onto the GCL side of the tissue and the responses recorded. Subsequently, the perfusate was switched back to control solution, and washout responses were recorded.
The light source was a 100-W tungsten-halogen lamp focused onto one end of a fiber optic. Stimulus duration was controlled with a shutter with a 6-mm aperture (Uniblitz; Vincent Associates, Rochester, NY). The energy output of the flashes was calibrated daily as the photon flux at the retinal surface in the Ussing chamber. Stimulus strength was controlled by a set of calibrated inconel neutral-density filters that allowed attenuation in steps of approximately 0.3 log units up to a maximum of 6.9 log units attenuation. The unattenuated stimulus was calibrated daily with an optical power meter (Graseby Optronics, Orlando, FL). We used a 505 nm (35 nm bandwidth) stimulus that was determined by a three-cavity interference filter (Andover Co., Salem, NH).
For the isolated-tissue experiments the number of photoisomerizations (R*) is given by the product of the stimulus strength, i (photons per square micrometer at max ), and A c , the effective collecting area of the outer segment, calculated using the equation by Baylor et al. 16 and Zhang et al. 17 :
where V OS is the volume of the outer segment, Q isom is the quantum efficiency of photoisomerization (0.67), 18 f is a factor allowing for the use of unpolarized light entering the outer segment perpendicular to its long axis (f ϭ 1 for end-on stimulus), and ␣ is the specific pigment density (0.016 m 20 and assuming a diameter of 1.5 m, giving an A c of 0.672 for rabbit rods.
Corneal ERGs
Rabbits (n ϭ 2) were first anesthetized with xylazine (10 mg/kg intramuscularly) and ketamine (50 mg/kg intramuscularly) and intubated for administration of a constant dose of 3% isoflurane (Attane; Minrad, Inc., Bethlehem, PA). Rabbits were kept warm by a heating pad (Braintree Scientific, Braintree, MA) during recording. They were dark adapted for at least 45 minutes before recording. Corneas were anesthetized with 0.5% proparacaine (Bausch Lomb, Tampa, FL) and the pupils dilated with topical 2.5% phenylephrine HCl (Bausch Lomb) and 1% tropicamide (Alcon Laboratories, Inc., Fort Worth, TX). In addition, a solution of 2.5% methylcellulose (Goniosol; CIBA Vision Corp., Duluth, GA) was used during and after the recording session to keep the corneas moist until the animal recovered from anesthesia. Gentamicin was administered by vitreous tap after baseline data collection. A 27-gauge needle was used to remove 0.1 mL of liquefied vitreous from 3.0 mm posterior to the limbus in the superotemporal quadrant of the eye. A 0.1 mL aliquot of 100 mg/mL gentamicin and buffered saline solution was then injected into the vitreous cavity of one eye of each animal and 0.1 mL buffered saline (pH 7.0) was injected into the contralateral eye with the identical technique.
An electrode designed after that described by Lyubarsky and Pugh 21 was placed on both eyes. Because of the large diameter of the electrode contacting the cornea (0.8 cm), an internal radius was added to act as a diverging lens. 22 A platinum wire loop was affixed to the tapered end of a Plexiglas rod that had been hollowed out to receive the fiber optic that delivered the light stimulus. This design ensured a constant distance between the fiber optic and the eye and also acted as a diffusing element. A second identical setup was placed on the other eye and served as the neutral electrode. To record the ERG from the control eye, we simply removed the fiber optic from one electrode holder and placed it in the other. Responses were amplified 5000ϫ under DC conditions with an amplifier (Astro-med CP122W; Grass Telefactor, W. Warwick, RI). The ERG voltage and stimulus monitor signals were digitized with hardware (MIO16) and software (LabView) from National Instruments (Austin, TX). Data were sampled at either 0.5 or 1.0 ms/point, and the ERG signal was low pass filtered at 300 Hz. A stimulus set typically consisted of 3 to 20 responses to the same intensity of light repeated at 2-to 10-second intervals. The energy output of the flashes was calibrated daily as the photon flux emitted from the fiber optic.
Histology
After 2 hours of ERG recording, both eyes were enucleated, the tissue fixed in 10% neutral-buffered formalin and embedded in paraffin. Serial sections through each globe were obtained and every fifth section stained with either toluidine blue or hematoxylin and eosin. Sections were examined by light microscopy by a single ophthalmic pathologist (RWR) in a masked fashion.
RESULTS
To examine the effect of intraocular gentamicin on retinal physiology, we performed ERGs on anesthetized rabbits. After baseline recording, scotopic conditions were maintained while a solution of 10 mg gentamicin was injected into the test eye, and a sham solution of buffered saline at the same pH was injected into the contralateral eye. DC ERGs performed before injection showed typical a-and b-waves. The response to a 4-second step of light revealed the c-waves (Fig. 1, black  traces) . Injection of buffered saline did not affect the ERG (Fig.  1a, gray trace) , whereas an injection of a solution of gentamicin eliminated the b-wave but left the a-wave intact (Fig. 1b, gray  trace) . The c-wave was reduced in amplitude. The inset in Figure 1 shows the b-wave on an expanded time axis. A similar result was obtained when this experiment was repeated in a second animal. After 2 hours of recording, the animal was killed and the eyes preserved for histologic examination.
Artifactual retinal detachment was present in some areas of both saline-and gentamicin-injected eyes. Histopathology of retinas from animals injected with gentamicin solution re-
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Aminoglycoside Retinal Toxicity 4805 vealed a greater degree of vacuolization of the nerve fiber layer and edema of the inner plexiform layer of the gentamicininjected eye than in the saline-injected eye (Fig. 2) . All histologic sections underwent identical, simultaneously applied fixation, embedding, and staining protocols. Despite this, sections of the saline-injected eye appeared more intensely stained, most likely a result of edema in the gentamicin-injected eye, with the increased fluid preventing dye uptake. Isolated-tissue ERG experiments were performed to test the reversibility of the gentamicin effect and to test its effect in both avascular (rabbit; Fig. 3 ) and vascular (rat; Fig. 4 ) retinas. Figure 3a shows the dim flash response (0.2 R*/rod). A 16-V response (black trace) was reduced to 6 V in the presence of 10 mg/mL gentamicin (blue trace). Figure 3b shows that a 57-fold brighter flash elicited a 46-V response (thick black trace), which was reduced to 30 V in the presence of gentamicin (gray trace). The response recovered rapidly on washout of the drug (thin gray trace). A bright flash ( Fig. 3c ; 2260 R*/rod) produced a 100-V a-wave and a small b-wave. The Müller cell contribution to the P III response, also known as the slow-P III , is very prominent, peaking at approximately 0.7 seconds and recovering with a time constant of approximately 1.1 seconds. Gentamicin eliminated the b-wave, but had no effect on the a-wave or the slow P III (Fig 3c; inset, gray trace) . Figure 4 demonstrates rapid and complete reversibility of gentamicin's effect on the isolated rat tissue ERG. In addition, to investigate the dose-dependence of gentamicin's effect on the b-wave, we exposed the isolated rat retina to one of two concentrations of gentamicin solutions. Figure 4a shows that a dim-light flash (2.0 R*/rod) generated a modest a-wave and a b-wave of approximately 150 V, which was reduced to less than half of its magnitude by exposure to gentamicin at a concentration of 1 mg/mL for less than 5 minutes. The thin gray trace in Figure 4a shows that the effect was completely reversible. Stimuli of 30 R*/rod produced the responses shown in Figure 4b . The b-wave produced by this bright flash was dramatically but reversibly reduced by a low concentration of gentamicin. A higher concentration of gentamicin (10 mg/mL) almost completely eliminated the b-wave response to a dim (Fig. 4c ). This larger effect was also reversible ( Fig. 4c ; thin gray trace). The brighter flashes produced larger a-waves that were enhanced or unmasked by gentamicin. The b-wave was completely eliminated by the 10-mg/mL concentration of gentamicin (Fig. 4d) ; the a-wave (fast P III ) and the slower Müller cell component (slow P III ) remained. The effects of the high concentration of gentamicin were also completely reversible (thin gray traces).
DISCUSSION
Although the clinical picture of retinal blanching in cases of gentamicin toxicity suggests a vascular process, our results indicate that another mechanism exists that directly interferes with retinal function. We found similar changes in retinal function in the presence of gentamicin in the rat retina, which has both choroidal and retinal vascular beds, and in the rabbit retina, which has only choroidal circulation. Selective loss of the b-wave occurred both in the whole-animal ERG and in isolated tissue. Therefore, gentamicin-induced changes occurred independent of retinal perfusion. The fact that our results show rapid and reversible effects in isolated tissue suggests that the immediate loss of vision occurs via a neural mechanism. There are several possibilities that explain why an initially neural process leads to a clinically vascular picture. It has been shown that numerous factors such as retinal metabolism, arterial oxygen content, and decreasing arterial pH influence retinal blood flow. 23 It is possible that gentamicin causes a profound alteration in retinal metabolism leading to vascular malfunction. It may be that the same cellular mechanisms that are disrupted leading to ERG changes also independently cause destruction in the vasculature.
Previous studies in primate and porcine retinas have shown the effects of intravitreal injection of gentamicin to include edema of the inner retina, similar to that in our animals. 10 -12 Hines et al. 12 examined porcine eyes 3 hours after injection of 3 mg gentamicin and found a small nerve fiber layer hemorrhage only. After 6 hours, they reported vacuolization of the nerve fiber layer, with these pathologic changes intensifying over time. In the current experiment, rabbit eyes were injected with 10 mg gentamicin. It is therefore possible that the histopathologic changes that occurred at earlier time points in the current study were a result of the higher dose of gentamicin. Factors specific to interspecies differences between rabbits and pigs are also a possible explanation.
It was somewhat surprising that the b-wave of the ERG was selectively affected. The simplest explanation for this finding is that bipolar function is impaired by gentamicin. Another possible explanation is that Müller cell function is damaged by gentamicin, which impairs bipolar cell function. We have found that the presence of antibiotics, especially gentamicin, in culture media dramatically reduces the viability of freshly isolated Müller cells (Ready RL, et al. IOVS 2004;45:ARVO E-Abstract 721). It is well known that Müller cells have numerous functions including regulation of retinal potassium homeostasis, 24 lactate formation, 25 and glutamate uptake. 26 If Müller cells are injured by gentamicin and subsequently unable to maintain electrolyte concentrations, then abnormal electrolyte concentrations may be reflected in the ERG. However, the c-wave of the ERG, which is in part due to a Müller cell potassium pumping function, was unchanged in our wholeanimal experiments. Also, the slow P III , which directly reflects the Müller cell function, was unchanged in our isolated-retina experiments. These findings argue against the idea that Müller cell toxicity is the origin of the ERG changes we observed.
The selective reduction in the b-wave in the presence of gentamicin could be explained by disruption of glutamate transport. Although neurons express glutamate transporters, glial cells are responsible for most uptake at the synapse. 27 Impairment of this important function by the glial cells would increase concentration of glutamate in the retina. The light response generated by bipolar cells is a response to decreased glutamate in the outer plexiform layer. If glutamate uptake mechanisms were impaired, high concentrations of glutamate would blind bipolar cells to the light response of photoreceptors, causing the b-wave to be diminished but allowing the aand c-waves to be maintained. Experiments that introduced glutamate analogues show reduced b-waves with delayed implicit times and unmasked a-waves. 28, 29 In our results as well, the a-wave was unmasked in the presence of gentamicin (Fig.  4) , suggesting no loss of photoreceptor function in the presence of gentamicin. Over time, glutamate is known to have toxic effects on the retina and leads to neuronal death. Application of glutamate to retinal tissue in vitro leads to histologic damage. 30 Furthermore, intravitreal injection of glutamate has been shown to induce retinal damage in rats. 31 This explanation is consistent with both the irreversible changes caused by long exposure to aminoglycosides and the reversibility of gentamicin's effect that we observed in short-term exposures (Figs. 3, 4) . Our results clearly demonstrate a neurotoxicity of gentamicin that may or may not be linked to the vascular events already described. Further elucidation of the mechanisms of aminoglycoside toxicity may allow for the design of drugs free of the neurotoxic side effects.
